Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc.

Day One is a biopharmaceutical company founded to address a critical unmet need - therapeutic development in pediatric cancers. Day One is committed to developing targeted therapies for patients with life-threatening diseases and redefine what’s possible for all people living with cancer, regardless of age, starting from Day One.

Yes

Central Nervous System Tumors, Head and Neck Cancer, Pediatric Cancer, Clinical Trials, Developmental Therapeutics, Drug Development, Molecular Diagnostics